PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia

Published:2015-07-09 Issue:2 Volume:126 Page:203-211
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

McClanahan Fabienne¹²,Hanna Bola²,Miller Shaun¹,Clear Andrew James¹,Lichter Peter²,Gribben John G.¹,Seiffert Martina²

Affiliation:

1. Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom; and

2. Molecular Genetics, German Cancer Research Center, Heidelberg, Germany

Abstract

Key Points In vivo PD-L1 blockade prevents CLL development in the Eµ-TCL1 adoptive transfer model. In vivo PD-L1 blockade normalizes T-cell and myeloid cell populations and immune effector functions.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/126/2/203/1389886/203.pdf

Reference41 articles.

1. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion.;Schreiber;Science,2011

2. The blockade of immune checkpoints in cancer immunotherapy.;Pardoll;Nat Rev Cancer,2012

3. The role of B7 family molecules in hematologic malignancy.;Greaves;Blood,2013

4. T cell exhaustion.;Wherry;Nat Immunol,2011

5. Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.;Burkhardt;J Clin Invest,2013

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia;Blood;2024-08-08

2. Blockade of PD-1 and TIM-3 Ameliorates CD8+ T Cell Exhaustion in a Mouse Model of Chronic Myeloid Leukemia;Cell Biochemistry and Biophysics;2024-07-12

3. The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment;Cancer Letters;2024-07

4. Lessons learned from the Eµ-TCL1 mouse model of CLL;Seminars in Hematology;2024-06

5. Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite;Cancer Cell;2024-06